Starting iron chelation therapy early may prevent growth problems and organ damage from iron overload in children with TDT. Currently approved medications have limitations for use in very young ...

Hemochromatosis is a condition that causes an overload of iron in the blood. Many people do not show any symptoms, but some experience fatigue and joint pain. It can either be inherited or caused by ...

Novartis announced that the Food and Drug Administration (FDA) has approved Jadenu (deferasirox) tablets for the treatment of chronic iron overload due to blood transfusions in patients ≥2 years old, ...

Dear Dr. Roach: I am a 65-year-old woman who was recently diagnosed with iron deficiency and sent to a hematologist for two sessions of iron infusion. After completing this procedure, I found out from ...

The National Heart, Lung, and Blood Institute (NHLBI) has stopped a clinical trial evaluating a new approach to reduce the risk of recurrent stroke in children with sickle cell anemia and iron ...

For people who need blood transfusions, iron can accumulate in the heart and liver, causing damage and sometimes death. Doctors often prescribe medications called chelators that bind to iron and ...

EAST HANOVER, N.J., January 23, 2013 /PRNewswire/ -- Novartis announced today that the US Food and Drug Administration (FDA) has approved Exjade ® (deferasirox) for the treatment of chronic iron ...

Three recent studies comparing oral iron chelators deferiprone (Ferriprox, Apotex) and deferasirox (Exjade, Novartis) with deferoxamine (Desferal, Novartis) suggest that the oral chelators clear iron ...

Three studies this year that compared the oral iron chelators deferiprone (Ferriprox, Apotex) and deferasirox (Exjade, Novartis) with deferoxamine (Desferal, Novartis) suggest that the oral chelators ...

Change in clinical practice would have clear benefits for patients undergoing major bowel surgery, according to analysis conducted by researchers from UCL and the Royal Devon and Exeter Hospital. The ...